Related Experiment Videos
Targeted retrograde gene delivery for neuronal protection
Brian K Kaspar1, Dawn Erickson, David Schaffer
1Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Summary
This study introduces a novel in vivo retrograde gene delivery method targeting central nervous system neurons. This approach successfully delivered therapeutic genes, protecting neurons from cell death and aiding neural circuit research.
Area of Science:
- Neuroscience
- Molecular Biology
- Gene Therapy
Background:
- Central nervous system (CNS) complexity hinders precise delivery of experimental and therapeutic agents.
- Mature projection neurons are challenging targets for gene delivery due to CNS circuitry.
Purpose of the Study:
- To develop and validate an in vivo retrograde gene delivery strategy targeting mature projection neurons.
- To assess the efficacy of adeno-associated virus (AAV) for retrograde gene transfer in the CNS.
- To demonstrate the therapeutic potential of this approach in protecting neurons from cell death.
Main Methods:
- Utilized adeno-associated virus (AAV) for in vivo retrograde gene delivery.
- Delivered viral vectors to axon terminal fields in the hippocampus and striatum.
- Analyzed viral internalization, retrograde transport, and transgene expression in projection neurons.
Main Results:
- Achieved successful viral internalization, retrograde transport, and transgene expression in specific projection neurons (entorhinal cortex, substantia nigra).
- Demonstrated protection of entorhinal projection neurons from damage-induced cell death using the anti-apoptotic gene Bcl2l (Bcl-xL).
Conclusions:
- Retrograde gene delivery offers a strategic method for therapeutic intervention in neurodegenerative diseases affecting widespread neural circuits.
- This technique facilitates targeted gene delivery to both terminal fields and projection neurons.
- The approach holds promise for advancing experimental studies of defined neural circuits.